tiprankstipranks
Advertisement
Advertisement

HAE Stock Latest News

Haemonetics price target lowered to $64 from $70 at Citi
The FlyHaemonetics price target lowered to $64 from $70 at Citi
5d ago
HAE
Haemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
PremiumRatings
Haemonetics: FDA Label Expansion and New Product Launches Poised to Reignite Vascular Closure Growth by FY27
12d ago
HAE
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
PremiumThe Fly
Haemonetics: FDA approves expanded labeling for VASCADE MVP XL system
12d ago
HAE
Haemonetics price target lowered to $70 from $75 at Citi
PremiumThe Fly
Haemonetics price target lowered to $70 from $75 at Citi
1M ago
HAE
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure
PremiumCompany Announcements
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure
1M ago
8K
HAE
Haemonetics receives FDA clearance for NexSys PCS Plasma Collection System
PremiumThe FlyHaemonetics receives FDA clearance for NexSys PCS Plasma Collection System
2M ago
HAE
Haemonetics Releases 2024-2025 Corporate Responsibility Report
Premium
Company Announcements
Haemonetics Releases 2024-2025 Corporate Responsibility Report
2M ago
8K
HAE
Haemonetics Earnings Call: Strong Core, IVT Drag
Premium
Company Announcements
Haemonetics Earnings Call: Strong Core, IVT Drag
2M ago
HAE
Haemonetics price target lowered to $81 from $99 at Baird
PremiumThe Fly
Haemonetics price target lowered to $81 from $99 at Baird
2M ago
HAE
Haemonetics price target lowered to $80 from $90 at Mizuho
PremiumThe Fly
Haemonetics price target lowered to $80 from $90 at Mizuho
2M ago
HAE
Haemonetics price target raised to $94 from $93 at Barrington
PremiumThe Fly
Haemonetics price target raised to $94 from $93 at Barrington
2M ago
HAE
Haemonetics price target lowered to $75 from $88 at Citi
PremiumThe Fly
Haemonetics price target lowered to $75 from $88 at Citi
2M ago
HAE
Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
PremiumThe FlyHaemonetics reports Q3 adjusted EPS $1.31, consensus $1.25
2M ago
HAE
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
Premium
The Fly
Haemonetics narrows FY26 adjusted EPS view to $4.90-$5.00 from $4.80-$5.00
2M ago
HAE
HAE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
HAE Upcoming Earnings Report: What to Expect?
2M ago
HAE
Balancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
PremiumRatings
Balancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
3M ago
HAE
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
PremiumThe Fly
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
3M ago
HAE
OBIO
Haemonetics price target raised to $93 from $90 at Barrington
PremiumThe Fly
Haemonetics price target raised to $93 from $90 at Barrington
3M ago
HAE
Haemonetics acquires Vivasure to expand structural heart portfolio
PremiumCompany Announcements
Haemonetics acquires Vivasure to expand structural heart portfolio
3M ago
8K
HAE
Haemonetics acquires Vivasure Medical for EUR 100M
PremiumThe FlyHaemonetics acquires Vivasure Medical for EUR 100M
3M ago
HAE
Haemonetics price target raised to $90 from $75 at Mizuho
Premium
The Fly
Haemonetics price target raised to $90 from $75 at Mizuho
4M ago
HAE
Haemonetics price target raised to $99 from $87 at Baird
Premium
The Fly
Haemonetics price target raised to $99 from $87 at Baird
4M ago
HAE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >